Author

Jodie R. Pietruska

Tufts University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Abraham L. BayeriD· 1 shared Anastasia GurinovichiD· 1 shared Aubrey Miller· 1 shared Benjamin Lewis· 1 shared Cheryl A. LondoniD· 1 shared Christina Lopes· 1 shared Garrett Harvey· 1 shared Gerald S PostiD· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Abraham L. BayerORCID

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCancersPeer-reviewedOct 12, 2023

AKT2 Loss Impairs BRAF-Mutant Melanoma Metastasis

Siobhan K. McRee, Abraham L. Bayer, Jodie R. Pietruska…·Philip W. Hinds

This study shows AKT2 promotes melanoma metastasis while AKT1 is critical for tumor initiation, suggesting AKT2 as a therapeutic target in BRAF-mutant melanoma.

9 citations

mousehuman

𝕏 PostBluesky

GenomicsVeterinary and Comparative OncologyPeer-reviewedSep 21, 2023

Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma

Timothy Estabrooks, Anastasia Gurinovich, Jodie R. Pietruska…·Kate Megquier

The paper identifies common genomic alterations in canine splenic hemangiosarcoma and links them to clinical outcomes and treatment responses.

15 citations

whole-exome sequencingstatistical model

𝕏 PostBluesky